This finding provides the evidence that LIN28B/IL-6/STAT3 signaling cascade may be involved in carcinogenesis of CCA and also suggests LIN28B and its downstream signaling may be an interesting therapeutic strategy for patients with CCA. The gene discussed is STAT3; the disease is cholangiocarcinoma.